Conference abstractPublished 30 Jun 2016
Complementary Drug Delivery Systems to Overcome Biological Barriers that Characterize Systemic Treatment
Houston Methodist Research Institute, (HMRI-Houston) USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biological barriers maintain the homeostasis between different compartments of the body and regulate the transport of every therapeutic administered systemically. Upon intravenous injection, the tumor vascular barrier, the tumor extracellular matrix and the tumor cell membrane barriers represent major obstacles hampering the delivery of the drug to the target. In this work we showed advanced surface modification that enable nanoparticles to overcome all these barriers allowing for a more efficient targeting of tumor microenvironment at a systemic, tissue and cellular level. Proteolipid surfaces coatings directly purified form the cell membrane of leukocytes allowed for the targeting and negotiation of tumor vascular barrier. Proteolytic coatings derived from the stem of the pineapple were efficient in increasing particle penetration and diffusion in tumor extracellular matrix in order to target hypoxic tumor region. Finally polymer science enabled synthetic carriers with pH responsiveness and ability to escape the endolysosomal compartment after internalization and to deliver a payload within the cytoplasm of the cells. A complete characterization of the different systems was performed through chemical technique and imaging analysis. Fluorescent and confocal microscopy was used to characterize the systems in vitro, while intravital microscopy allowed for determining particle targeting and bioactivity. In this work we showed different techniques to negotiate and overcome several biological barriers that stand and between the administration point and the target.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- SubjectAlternative & Palliative Care
- BylineArticles whose byline prints “Alessandro Parodi”